Suppr超能文献

以淋巴结炎为表现的类鼻疽:病例报告

Melioidosis presenting as lymphadenitis: a case report.

作者信息

Wijekoon Sanjeewa, Prasath Thushanthy, Corea Enoka M, Elwitigala Jayanthi P

机构信息

University Medical Unit, Colombo South Teaching Hospital, Kalubowila, Sri Lanka.

出版信息

BMC Res Notes. 2014 Jun 14;7:364. doi: 10.1186/1756-0500-7-364.

Abstract

BACKGROUND

Melioidosis is an infection caused by the facultative intracellular gram-negative bacterium; Burkholderia pseudomallei. It gives rise to protean clinical manifestations and has a varied prognosis. Although it was rare in Sri Lanka increasing numbers of cases are being reported with high morbidity and mortality. Here we report a case of melioidosis presenting with lymphadenitis which was diagnosed early and treated promptly with a good outcome.

CASE PRESENTATION

A 53-year-old Sinhalese woman with diabetes presented with fever and left sided painful inguinal lymphadenitis for one month. She had undergone incision and drainage of a thigh abscess three months previously and had been treated with a short course of antibiotics. There was no record that abscess material was tested microbiologically.She had neutrophil leukocytosis and elevated inflammatory markers. Initial pus culture revealed a scanty growth of "Pseudomonas sp." and Escherichia coli which were sensitive to ceftazidime and resistant to gentamicin.Due to the history of diabetes, recurrent abscess formation and the suggestive sensitivity pattern of the bacterial isolates, we actively investigated for melioidosis. The bacterial isolate was subsequently identified as B. pseudomallei by polymerase chain reaction and antibodies to melioidin antigen were found to be raised at a titre of 1:160.The patient was treated with high dose intravenous ceftazidime for four weeks followed by eradication therapy with cotrimoxazole and doxycycline. As the patient was intolerant to cotrimoxazole, the antibiotics were changed to a combination of co-amoxyclav and doxycycline and continued for 12 weeks. The patient was well after 6 months without any relapse.

CONCLUSIONS

Melioidosis is an emerging infection in South Asia. It may present with recurrent abscesses. Therefore it is very important to send pus for culture whenever an abscess is drained. However, it should be noted that the reporting laboratory may be unfamiliar with this bacterium and the isolate may be misidentified as Pseudomonas or even E. coli. Melioidosis should be suspected when an isolate with the typical antibiotic sensitivity pattern of ceftazidime sensitivity and gentamicin resistance is cultured, especially in a patient with diabetes. This will expedite diagnosis and prompt treatment leading to an excellent prognosis.

摘要

背景

类鼻疽是由兼性胞内革兰氏阴性菌——伯克霍尔德菌属假鼻疽杆菌引起的一种感染。它会引发多种临床表现,预后各异。尽管在斯里兰卡这种病较为罕见,但报告的病例数量正在增加,且发病率和死亡率都很高。在此,我们报告一例以淋巴结炎为表现的类鼻疽病例,该病例得到了早期诊断并及时治疗,预后良好。

病例介绍

一名53岁患糖尿病的僧伽罗族女性,出现发热及左侧腹股沟疼痛性淋巴结炎1个月。3个月前她曾接受大腿脓肿切开引流术,并接受了短期抗生素治疗。没有记录显示脓肿材料进行过微生物学检测。她有中性粒细胞增多症及炎症标志物升高。最初的脓液培养显示“假单胞菌属”和大肠杆菌生长稀少,这些细菌对头孢他啶敏感,对庆大霉素耐药。鉴于其糖尿病病史、反复脓肿形成以及细菌分离株提示的敏感性模式,我们积极排查类鼻疽。随后通过聚合酶链反应将细菌分离株鉴定为假鼻疽杆菌,并且发现抗类鼻疽菌素抗原的抗体滴度升至1:160。患者接受了4周高剂量静脉注射头孢他啶治疗,随后用复方新诺明和多西环素进行根除治疗。由于患者对复方新诺明不耐受,抗生素改为阿莫西林克拉维酸和多西环素联合使用,并持续12周。6个月后患者情况良好,无任何复发。

结论

类鼻疽在南亚是一种新出现的感染。它可能表现为反复脓肿。因此,每当脓肿引流时,将脓液送去培养非常重要。然而,应该注意的是,报告实验室可能不熟悉这种细菌,分离株可能被误鉴定为假单胞菌甚至大肠杆菌。当培养出具有头孢他啶敏感和庆大霉素耐药的典型抗生素敏感性模式的分离株时,尤其是在糖尿病患者中,应怀疑类鼻疽。这将加快诊断和及时治疗,从而带来良好的预后。

相似文献

7

引用本文的文献

5
Melioidosis in Sri Lanka.斯里兰卡的类鼻疽病。
Trop Med Infect Dis. 2018 Feb 21;3(1):22. doi: 10.3390/tropicalmed3010022.

本文引用的文献

1
The Treatment of Melioidosis.类鼻疽的治疗
Pharmaceuticals (Basel). 2010 Apr 27;3(5):1296-1303. doi: 10.3390/ph3051296.
2
A rare cause of septic arthritis: melioidosis.脓毒性关节炎的一种罕见病因:类鼻疽。
Trop Doct. 2013 Oct;43(4):164-6. doi: 10.1177/0049475513505091. Epub 2013 Sep 25.
6
Melioidosis in northern Australia, 2001-02.2001 - 2002年澳大利亚北部的类鼻疽病
Commun Dis Intell Q Rep. 2003;27(2):272-7. doi: 10.33321/cdi.2003.27.52.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验